Literature DB >> 17900623

Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.

Kristin Gellein1, Jon H Skogholt, Jan Aaseth, Gunnar B Thoresen, Syverin Lierhagen, Eiliv Steinnes, Tore Syversen, Trond Peder Flaten.   

Abstract

A hereditary neurological disease in a family in Norway has been reported recently. The disease, which we refer to as Skogholt's disease, is a demyelinating disorder of both the central and the peripheral nervous system with adult onset. We investigated whether changes in trace element concentrations could play a role in Skogholt's disease. Using high resolution inductively coupled plasma mass spectrometry, we determined 31 elements in cerebrospinal fluid (CSF), blood plasma and whole blood from these patients, multiple sclerosis patients and a control group. More than threefold increased levels of Cu and Fe, and a twofold increase in Zn were found in the CSF of Skogholt patients compared to controls. Several other significant differences in trace element levels were also found. The increased levels of Cu and Fe in CSF may indicate an active role of these metals in the pathogenesis of Skogholt's disease. Apparently, these metal ions are transferred into the CSF through their protein chelation, as raised protein levels were also seen. We suggest that redistribution of metals from transport proteins into vulnerable sites in the central (and peripheral) nervous system may initiate critical lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900623     DOI: 10.1016/j.jns.2007.08.042

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Significance of Low Nanomolar Concentration of Zn2+ in Artificial Cerebrospinal Fluid.

Authors:  Atsushi Takeda; Haruna Tamano
Journal:  Mol Neurobiol       Date:  2016-03-16       Impact factor: 5.590

2.  Manganese and selenium concentrations in cerebrospinal fluid of seriously ill children.

Authors:  Tomáš Franěk; Karel Kotaška; Richard Průša
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

Review 3.  The Impact of Synaptic Zn2+ Dynamics on Cognition and Its Decline.

Authors:  Atsushi Takeda; Hanuna Tamano
Journal:  Int J Mol Sci       Date:  2017-11-14       Impact factor: 5.923

4.  In vitro and in vivo physiology of low nanomolar concentrations of Zn2+ in artificial cerebrospinal fluid.

Authors:  Haruna Tamano; Ryusuke Nishio; Yukina Shakushi; Miku Sasaki; Yuta Koike; Misa Osawa; Atsushi Takeda
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

5.  Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements.

Authors:  Alessandra Nicoletti; Elisa Bruno; Martina Nania; Edoardo Cicero; Silvia Messina; Clara Chisari; Josita Torrisi; Davide Maimone; Roberto Marziolo; Salvatore Lo Fermo; Francesco Patti; Salvatore Giammanco; Mario Zappia
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

6.  Comparison of serum Concentration of Se, Pb, Mg, Cu, Zn, between MS patients and healthy controls.

Authors:  Anahita Alizadeh; Omid Mehrpour; Karim Nikkhah; Golnaz Bayat; Mahsa Espandani; Alireza Golzari; Lida Jarahi; Mohsen Foroughipour
Journal:  Electron Physician       Date:  2016-08-25

Review 7.  Zinc in Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Mikkel Bredholt; Jette Lautrup Frederiksen
Journal:  ASN Neuro       Date:  2016-06-09       Impact factor: 4.146

8.  Can volcanic trace elements facilitate Covid-19 diffusion? A hypothesis stemming from the Mount Etna area, Sicily.

Authors:  Loredana Raciti; Rocco Salvatore Calabrò
Journal:  Med Hypotheses       Date:  2020-06-27       Impact factor: 1.538

9.  Lower Serum Zinc Levels in Patients with Multiple Sclerosis Compared to Healthy Controls.

Authors:  Marc Pawlitzki; Julia Uebelhör; Catherine M Sweeney-Reed; Heike Stephanik; Juliane Hoffmann; Anke Lux; Dirk Reinhold
Journal:  Nutrients       Date:  2018-07-26       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.